Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Nov 27 2024

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 27, 2024, titled "Glenmark Pharmaceuticals Inc., USA launches Travoprost Ophthalmic Solution USP, 0.004%(Ionic Buffered Solution)".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases